PL365739A1 - Substituted imidazopyridines - Google Patents

Substituted imidazopyridines

Info

Publication number
PL365739A1
PL365739A1 PL01365739A PL36573901A PL365739A1 PL 365739 A1 PL365739 A1 PL 365739A1 PL 01365739 A PL01365739 A PL 01365739A PL 36573901 A PL36573901 A PL 36573901A PL 365739 A1 PL365739 A1 PL 365739A1
Authority
PL
Poland
Prior art keywords
substituted imidazopyridines
imidazopyridines
substituted
Prior art date
Application number
PL01365739A
Other languages
English (en)
Polish (pl)
Inventor
Kyle J. Lindstrom
Original Assignee
3M Innovative Properties Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company
Publication of PL365739A1 publication Critical patent/PL365739A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
PL01365739A 2000-12-08 2001-12-06 Substituted imidazopyridines PL365739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25422800P 2000-12-08 2000-12-08
PCT/US2001/046915 WO2002046194A2 (fr) 2000-12-08 2001-12-06 Imidazopyridines substituees

Publications (1)

Publication Number Publication Date
PL365739A1 true PL365739A1 (en) 2005-01-10

Family

ID=22963437

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365739A PL365739A1 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines

Country Status (24)

Country Link
EP (1) EP1343783A2 (fr)
JP (1) JP2004525868A (fr)
KR (1) KR20030070048A (fr)
CN (1) CN1249062C (fr)
AR (1) AR035670A1 (fr)
AU (2) AU3954702A (fr)
BR (1) BR0116034A (fr)
CA (1) CA2431040A1 (fr)
CZ (1) CZ20031593A3 (fr)
EE (1) EE200300273A (fr)
HK (1) HK1063466A1 (fr)
HR (1) HRP20030465A2 (fr)
HU (1) HUP0600592A2 (fr)
IL (1) IL155885A0 (fr)
MX (1) MXPA03005013A (fr)
NO (1) NO20032453L (fr)
NZ (1) NZ526085A (fr)
PL (1) PL365739A1 (fr)
RU (1) RU2294934C2 (fr)
SK (1) SK7142003A3 (fr)
TW (1) TWI243819B (fr)
UA (1) UA74593C2 (fr)
WO (1) WO2002046194A2 (fr)
ZA (1) ZA200305238B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6660735B2 (en) 2000-12-08 2003-12-09 3M Innovative Properties Company Urea substituted imidazoquinoline ethers
US6677347B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
US20020107262A1 (en) * 2000-12-08 2002-08-08 3M Innovative Properties Company Substituted imidazopyridines
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6525064B1 (en) 2000-12-08 2003-02-25 3M Innovative Properties Company Sulfonamido substituted imidazopyridines
UA75622C2 (en) 2000-12-08 2006-05-15 3M Innovative Properties Co Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
NZ532769A (en) 2001-11-29 2005-12-23 3M Innovative Properties Co Pharmaceutical formulations comprising an immune response modifier
CA2365732A1 (fr) 2001-12-20 2003-06-20 Ibm Canada Limited-Ibm Canada Limitee Etalonnages
WO2003101949A2 (fr) * 2002-05-29 2003-12-11 3M Innovative Properties Company Procede permettant d'obtenir des imidazo[4,5-c]pyridin-4-amines
EP1545597B1 (fr) 2002-08-15 2010-11-17 3M Innovative Properties Company Compositions immunostimulantes et procedes de stimulation d'une reponse immune
US6818650B2 (en) 2002-09-26 2004-11-16 3M Innovative Properties Company 1H-imidazo dimers
WO2004058759A1 (fr) 2002-12-20 2004-07-15 3M Innovative Properties Company Imidazoquinoleines a substitution aryle/heteroaryle
EP2572714A1 (fr) 2002-12-30 2013-03-27 3M Innovative Properties Company Combinaisons immunostimulantes
CA2517528A1 (fr) 2003-03-04 2004-09-16 3M Innovative Properties Company Traitement prophylactique de la neoplasie epidermique induite par les uv
EP1608282A4 (fr) * 2003-03-13 2010-12-08 3M Innovative Properties Co Methodes de diagnostic de lesions de la peau
BRPI0408476A (pt) 2003-03-13 2006-04-04 3M Innovative Properties Co métodos para melhorar a qualidade da pele
US20040192585A1 (en) 2003-03-25 2004-09-30 3M Innovative Properties Company Treatment for basal cell carcinoma
JP2007500210A (ja) 2003-04-10 2007-01-11 スリーエム イノベイティブ プロパティズ カンパニー 金属含有微粒子担体材料を使用した免疫反応調節物質化合物の送達
WO2004110991A2 (fr) 2003-06-06 2004-12-23 3M Innovative Properties Company PROCESSUS DE PREPARATION D'IMIDAZO[4,5-c]PYRIDINE-4-AMINES
AU2004266658A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
WO2005020912A2 (fr) 2003-08-25 2005-03-10 3M Innovative Properties Company Administration de composes modificateurs de la reponse immunitaire
KR101106812B1 (ko) 2003-08-27 2012-01-19 쓰리엠 이노베이티브 프로퍼티즈 컴파니 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
EP1660026A4 (fr) 2003-09-05 2008-07-16 3M Innovative Properties Co Traitement pour le lymphome a cellules b cd5+
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
JP5043435B2 (ja) 2003-10-03 2012-10-10 スリーエム イノベイティブ プロパティズ カンパニー アルコキシ置換イミダゾキノリン
EP1685129A4 (fr) 2003-11-14 2008-10-22 3M Innovative Properties Co Composes d'un anneau d'imidazo substitues par oxime
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
WO2005051317A2 (fr) 2003-11-25 2005-06-09 3M Innovative Properties Company Systèmes cycliques d'imidazo substitués et procédés
US8940755B2 (en) 2003-12-02 2015-01-27 3M Innovative Properties Company Therapeutic combinations and methods including IRM compounds
CA2552101A1 (fr) * 2003-12-29 2005-07-21 3M Innovative Properties Company Composes de cycles accoles imidazo de piperazine, [1,4]diazepane, [1,4]diazocane, et [1,5]diazocane
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
WO2005094531A2 (fr) 2004-03-24 2005-10-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (fr) 2004-06-18 2006-06-22 3M Innovative Properties Company Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006083440A2 (fr) 2004-12-30 2006-08-10 3M Innovative Properties Company Composes chiraux [1,2]imidazo[4,5-c] substitues a noyau fusionne
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
CA2597092A1 (fr) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Formulations des gel aqueux contenant des modificateurs de reponse immunitaire
EP1846405A2 (fr) 2005-02-11 2007-10-24 3M Innovative Properties Company Composes cycliques imidazo 4,5-c substitues par oxime et hydroxylamine et procedes associes
CA2602590A1 (fr) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
KR20080048551A (ko) * 2005-09-23 2008-06-02 콜레이 파마시티컬 그룹, 인코포레이티드 1Ｈ-이미다조[4,5-ｃ]피리딘 및 그의 유사체의 제조법
CN100344325C (zh) * 2005-10-17 2007-10-24 华南师范大学 一种治疗宫颈癌的药物及其制备方法与应用
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
WO2009034411A1 (fr) * 2007-09-12 2009-03-19 Centre National De La Recherche Scientifique Perharidines en tant qu'inhibiteurs de cdk
CN112587658A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
CN105814052B (zh) * 2013-12-09 2018-01-12 Ucb生物制药私人有限公司 作为tnf活性调节剂的咪唑并吡啶衍生物
AU2015205755C1 (en) 2014-01-10 2020-08-13 Birdie Biopharmaceuticals Inc. Compounds and compositions for immunotherapy
CN112546231A (zh) 2014-07-09 2021-03-26 博笛生物科技有限公司 用于治疗癌症的联合治疗组合物和联合治疗方法
KR102462743B1 (ko) 2014-07-09 2022-11-02 버디 바이오파마슈티칼즈, 인크. 종양 치료용 항-pd-l1 조합
CN112587672A (zh) 2014-09-01 2021-04-02 博笛生物科技有限公司 用于治疗肿瘤的抗-pd-l1结合物
CN115252792A (zh) 2016-01-07 2022-11-01 博笛生物科技有限公司 用于治疗肿瘤的抗-egfr组合
CN115350279A (zh) 2016-01-07 2022-11-18 博笛生物科技有限公司 用于治疗肿瘤的抗-her2组合
CN115554406A (zh) 2016-01-07 2023-01-03 博笛生物科技有限公司 用于治疗肿瘤的抗-cd20组合
CN108794467A (zh) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-氨基-喹啉衍生物
EP3641771A4 (fr) 2017-06-23 2020-12-16 Birdie Biopharmaceuticals, Inc. Compositions pharmaceutiques

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
DK0708772T3 (da) * 1993-07-15 2000-09-18 Minnesota Mining & Mfg Imidazo[4,5,-c]pyridin-4-aminer
WO1998030562A1 (fr) * 1997-01-09 1998-07-16 Terumo Kabushiki Kaisha Nouveaux derives d'amide et intermediaires utilises pour leur synthese
UA67760C2 (uk) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6541485B1 (en) * 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6331539B1 (en) * 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6451810B1 (en) * 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines

Also Published As

Publication number Publication date
TWI243819B (en) 2005-11-21
UA74593C2 (en) 2006-01-16
HK1063466A1 (en) 2004-12-31
WO2002046194A2 (fr) 2002-06-13
HUP0600592A2 (en) 2006-11-28
RU2003116648A (ru) 2005-02-10
AR035670A1 (es) 2004-06-23
ZA200305238B (en) 2004-08-27
CN1249062C (zh) 2006-04-05
HRP20030465A2 (en) 2004-06-30
EE200300273A (et) 2004-02-16
CA2431040A1 (fr) 2002-06-13
BR0116034A (pt) 2004-08-03
SK7142003A3 (en) 2003-10-07
CN1478090A (zh) 2004-02-25
CZ20031593A3 (cs) 2004-01-14
JP2004525868A (ja) 2004-08-26
NO20032453D0 (no) 2003-05-28
AU3954702A (en) 2002-06-18
NO20032453L (no) 2003-07-16
WO2002046194A3 (fr) 2003-02-06
IL155885A0 (en) 2003-12-23
AU2002239547B2 (en) 2006-11-30
RU2294934C2 (ru) 2007-03-10
EP1343783A2 (fr) 2003-09-17
KR20030070048A (ko) 2003-08-27
NZ526085A (en) 2004-12-24
MXPA03005013A (es) 2003-09-05

Similar Documents

Publication Publication Date Title
AU3954702A (en) Substituted imidazopyridines
EG24669A (en) Antivral azaindole derivatives
GB2364651B (en) Golf-putters
DZ3293A1 (fr) Arylpyrazines substitues
AU3391801A (en) Pyridinylimidazoles
AU6227101A (en) Substituted iminoazines
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
DE50110354D1 (en) Achsantriebsblock mit differentialsperre
TWI315197B (en) Combinations
PL358119A1 (en) Substituted phenyluracils
AU5825501A (en) Substituted benzoylcyclohexenones
AU6619001A (en) Liquid-pourers
IL152154A0 (en) Sulfonamide-derivatives
AU4686401A (en) Hypotensors
AU4831301A (en) Gm-negative ehv-mutants
DE60107852D1 (en) Thienopyrrolidinone
AU2360402A (en) Substituted phenyluracils
GB0017591D0 (en) Pipe-chamfering means
AU2117P (en) Gauka Gaura lindheimeri
AU1852P (en) Tickit xTriticosecale
GB0022997D0 (en) Disclosure
AU141656S (en) Eartag
AU148684S (en) Numberplate
AU148665S (en) Numberplate

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)